Kristina Fiore
  • Bio
  • Mentions
Picture
Nasal Naloxone Price Set to Jump
MEDPAGE TODAY

Eliza Wheeler and several volunteers sit on the floor of her office and pack naloxone kits. They package up rubber gloves, rescue breathing masks, alcohol pads, and two atomizers. And, of course, the key ingredient: two cartridges of nasal naloxone -- an old drug that can reverse an opioid overdose in seconds. Problem is, the price of naloxone is doubling, and community groups like Wheeler's may not be able to afford it.

READ MORE ... 


Picture

Injecting Opana Tied to Blood Clotting Disorder
MEDPAGE TODAY

Shooting up Opana landed 38-year-old James Gibbons in the hospital -- but not because of an overdose.
Read More
Picture

Benzo 'Boost' Can Be Deadly
MILWAUKEE JOURNAL SENTINEL

Thousands of Americans are dying each year after mixing opioids and benzodiazepines.
Read More
Picture

Can a Genetic Test Predict Opioid Addiction Risk?
 ​
MILWAUKEE JOURNAL SENTINEL

Two companies are selling doctors tests they say can predict risk of opioid addiction based on a patient's genes. But experts say they're getting ahead of the science.
Read More
MORE STORIES:

FDA Panel Splits on Naloxone Dose

Long-Acting Morphine Wins FDA Advisors' Support

Some Spared HIV Infection in Indiana Opana-Related Outbreak

Pfizer's Troxyca Gets Mixed Review from FDA Advisors

FDA Advisors OK Abuse-Deterrent Opioid, Despite Concerns

Novel Opioid Not Abuse-Deterrent, FDA Panel Says

Opioids: Mandate Education for Prescribers


Opioid REMS Impact Unclear

Opioid Crisis: Scrap Pain as 5th Vital Sign?
​
FDA Releases Draft Plan for Abuse-Deterrent Opioid Generics


Short-Acting Opioids Get New Boxed Warning

HHS Issues Pain Strategy, With No Fanfare

CDC Comes Down Hard on Opioids for Chronic Pain

FDA Science Advisors Talk Strategy on Opioids

Vicodin Scripts Down After Tighter Controls
​

Docs on Board with CDC Opioid Guidance

Will Delay Weaken CDC Opioid Guidance?

FDA Comments on Nasal Naloxone Dose Concerns
​

Naloxone for Opioid Overdose: Questions About Dosing

Opioid Overdose Deaths Keep Rising

FDA Panels Like New Abuse-Deterrent Opioid

FDA Panels Nix Roxicodone Reformulation

Purdue Pulls New OxyContin Application, & Questions Follow

On-Label Naloxone in the Works

Abandoned Painkiller Makes a Comeback

Injecting Opana Tied to Blood Clotting Disorder

Congress Pressures FDA to Finalize Opioid Guidance

No Easing in Opioid Death Toll

Scant Evidence for Opioids in Chronic Pain

Nasal Naloxone Price Set to Jump

FDA Okays Abuse-Deterrent Hydrocodone

FDA Focuses on Abuse-Deterrent Opioids

FDA Okays Third Abuse-Deterrent Opioid

Different Dataset, Same Result: Heroin Deaths Rising

AAN Warns Against Opioids in Chronic Pain

‘Abuse-Deterrent’ Label Panned for New Opioid

Opioid, Heroin Deaths Continue to Climb

FDA Panel Snubs Morphine-Oxycodone Combo

FDA Opioid Rulings Slammed

Schumer to HHS: Ditch Zohydro

Senators Investigate Alleged Zohydro Pay-to-Play

Groups Ask FDA to Reconsider Zohydro Approval

Killing Pain: Script by Script // MJS.com

Killing Pain: Fewer Opioid Scripts // MJS.com

Killing Pain: Tranquilizer Nation Timeline

Killing Pain: Xanax Tops Charts // MJS.com

Killing Pain: Benzo ‘Boost’ Can Be Deadly // MJS.com

28 Attorneys General Ask FDA to Reconsider Zohydro Approval

FDA Okays High-Dose Narcotic Painkiller Zohydro, Raising Abuse Concerns // MJS.com

No Abuse Protection in New Painkiller Zohydro // with the Milwaukee Journal Sentinel

FDA Plans to Restrict Vicodin Rx // with the Milwaukee Journal Sentinel

FDA Tightens Reins on Long-Acting Opioids

FDA Allows Opana Generics

FDA Updates OxyContin Label, Blocks Generics

Pain Groups Offer Alternatives to Label Changes

Opioid Labeling Debated at FDA Hearing

FDA Panel Votes for Tighter Controls on Vicodin

Abuse of ‘New’ Opana Linked to Blood Disorder

FDA Unveils Tamper-Resistant Opioid Plan

Abuse Resistance an Issue with Opioid Generics

Vicodin Triggers Interagency War

FDA: Don’t Tighten Vicodin Regulation

Docs Feel Pressure to Give Addicts Opioids

More Addictions Treated with Drug Therapy

Report: Rx Monitoring Plans Flawed

Critis: Opioid REMS Misses Mark on Patient Education

FDA’s Opioid Control Plan Slammed

OxyContin Remake Sends Abusers to Other Opioids

FDA Finalizes Opioid Education Plan

FDA Closes Doors on Unapproved Pain Meds

NY Lawmakers Pass Narcotic Painkiller Bill

New York Clamps Down on Narcotic Painkillers

Feds Analyze, Target Painkiller Abuse

DEA Targets Retailers to Curb Rx Drug Abuse

Physician Group Challenges IOM Pain Report

Rescheduling Hydrocodone 

Generic Vicodin Easiest Opioid to Prescribe

Critics Wary of FDA’s REMS for Long-Acting Opioids

White House Targets Painkiller Abuse

Companies Attempt Abuse-Proof Opioids

Deaths from Rx Painkillers Still Rising, CDC Says

Year in Review: Mitigating Opioid Risks

Barriers Remain for Primary Care Tx of Addicts


Powered by Create your own unique website with customizable templates.
  • Bio
  • Mentions